Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bell

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Molecular Microbiology|July 5, 2014
Characterization of mutations in the PAS domain of the EvgS sensor kinase selected by laboratory evolution for acid resistance in Escherichia coliMatthew D Johnson, James Bell, Kim Clarke, et al.
Investigative Ophthalmology & Visual Science|January 23, 2026
The Structural Order of Crystallin Proteins During Early Human Lens DevelopmentKiranjit K Bains, James Bell, Robert D Young, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Ranking the harm of non-medically used prescription opioids in the UKJan van Amsterdam, Lawrence Phillips, Graeme Henderson, et al.
PLOS Global Public Health|December 5, 2024
Knowledge, uptake and intention to use antibiotic post-exposure prophylaxis and meningococcal B vaccine (4CMenB) for gonorrhoea among a large, online community sample of men and gender-diverse individuals who have sex with men in the UKDana Ogaz, Jessica Edney, Dawn Phillips, et al.
Drug and Alcohol Dependence|April 4, 2017
Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trialAdrian J Dunlop, Amanda L Brown, Christopher Oldmeadow, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
Sexually Transmitted Infections|July 15, 2025
'It does fill me with a bit of unease': a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with menWilliam Berners-Lee, Melissa Cabecinha, James Bell, et al.
The International Journal on Drug Policy|March 4, 2025
Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in AustraliaAlison Ritter, James Bell, John Strang, et al.
Sexually Transmitted Infections|December 30, 2025
Foundations for progress: insights from the PrEP Impact Trial supporting change to PrEP delivery and implementation in EnglandDana Ogaz, Holly Mitchell, Chiara Chiavenna, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Molecular Microbiology|July 5, 2014
Characterization of mutations in the PAS domain of the EvgS sensor kinase selected by laboratory evolution for acid resistance in Escherichia coliMatthew D Johnson, James Bell, Kim Clarke, et al.
Investigative Ophthalmology & Visual Science|January 23, 2026
The Structural Order of Crystallin Proteins During Early Human Lens DevelopmentKiranjit K Bains, James Bell, Robert D Young, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Ranking the harm of non-medically used prescription opioids in the UKJan van Amsterdam, Lawrence Phillips, Graeme Henderson, et al.
PLOS Global Public Health|December 5, 2024
Knowledge, uptake and intention to use antibiotic post-exposure prophylaxis and meningococcal B vaccine (4CMenB) for gonorrhoea among a large, online community sample of men and gender-diverse individuals who have sex with men in the UKDana Ogaz, Jessica Edney, Dawn Phillips, et al.
Drug and Alcohol Dependence|April 4, 2017
Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trialAdrian J Dunlop, Amanda L Brown, Christopher Oldmeadow, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
Sexually Transmitted Infections|July 15, 2025
'It does fill me with a bit of unease': a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with menWilliam Berners-Lee, Melissa Cabecinha, James Bell, et al.
The International Journal on Drug Policy|March 4, 2025
Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in AustraliaAlison Ritter, James Bell, John Strang, et al.
Sexually Transmitted Infections|December 30, 2025
Foundations for progress: insights from the PrEP Impact Trial supporting change to PrEP delivery and implementation in EnglandDana Ogaz, Holly Mitchell, Chiara Chiavenna, et al.
Pageof 13